Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Brendan Osborne"'
Autor:
Shawn Malone, Christopher J. D. Wallis, Richard Lee‐Ying, Naveen S. Basappa, Ilias Cagiannos, Robert J. Hamilton, Ricardo Fernandes, Cristiano Ferrario, Geoffrey T. Gotto, Scott C. Morgan, Christopher Morash, Tamim Niazi, Krista L. Noonan, Ricardo Rendon, Sebastien J. Hotte, Fred Saad, Anousheh Zardan, Brendan Osborne, Katherine F. Y. Chan, Bobby Shayegan
Publikováno v:
BJUI Compass, Vol 3, Iss 5, Pp 383-391 (2022)
Abstract Objectives To describe patterns of practice of PSA testing and imaging for Ontario men receiving continuous ADT for the treatment of non‐metastatic castration‐resistant prostate cancer (nmCRPC). Patients and Methods This was a retrospect
Externí odkaz:
https://doaj.org/article/3f6b6dfc44aa41928642415c19d064c2
Autor:
Geoffrey T. Gotto, Steven M. Yip, Bobby Shayegan, Dylan E. O'Sullivan, Christopher J.D. Wallis, Naveen S. Basappa, Ilias Cagiannos, Robert James Hamilton, Cristiano Ferrario, Ricardo Fernandes, Brita Danielson, Fred Saad, Sebastien J. Hotte, Darren R. Brenner, Winson Y. Cheung, Devon J. Boyne, Katherine Chan, Brendan Osborne, Anousheh Zardan, Shawn Malone
Publikováno v:
Journal of Clinical Oncology. 41:76-76
76 Background: In recent years, treatment intensification beyond androgen deprivation therapy (ADT) with several novel therapies have shown survival benefit in patients with metastatic castration-sensitive prostate cancer (mCSPC). Given the rapidly e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7353f96b672bd3b877719f4f7d1f3a01
https://doi.org/10.1200/jco.2023.41.6_suppl.76
https://doi.org/10.1200/jco.2023.41.6_suppl.76
Autor:
Bobby Shayegan, Christopher J.D. Wallis, Shawn Malone, Ilias Cagiannos, Robert J. Hamilton, Cristano Ferrario, Geoffrey T. Gotto, Naveen S. Basappa, Scott C. Morgan, Ricardo Fernandes, Christopher Morash, Tamim Niazi, Krista L. Noonan, Ricardo Rendon, Brendan Osborne, Laura Park-Wyllie, Katherine F.Y. Chan, Sebastien J. Hotte, Fred Saad
Publikováno v:
Urologic oncology. 40(5)
Management of advanced prostate cancer has evolved rapidly with the availability of multiple systemic treatments such as androgen-receptor axis-targeted therapies (ARATs), taxane-based chemotherapy, radium-223, and other approaches. However, limited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00745f7271b44aa888556769a8746c4a
https://pubmed.ncbi.nlm.nih.gov/35216890
https://pubmed.ncbi.nlm.nih.gov/35216890
Autor:
Shawn Malone, Christopher J.D. Wallis, Richard M. Lee-Ying, Naveen S. Basappa, Ilias Cagiannos, Robert James Hamilton, Ricardo Fernandes, Cristiano Ferrario, Geoffrey Gotto, Scott Carlyle Morgan, Chris Morash, Tamim Niazi, Krista Noonan, Ricardo A. Rendon, Sebastien J. Hotte, Fred Saad, Anousheh Zardan, Brendan Osborne, Katherine Chan, Bobby Shayegan
Publikováno v:
Journal of Clinical Oncology. 40:53-53
53 Background: To describe patterns of practice of PSA testing and imaging for Ontario men receiving continuous androgen deprivation therapy (ADT) for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC). Methods: This was a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24292ef31e80f6c8525f48a0b54fc36c
https://doi.org/10.1200/jco.2022.40.6_suppl.053
https://doi.org/10.1200/jco.2022.40.6_suppl.053
Publikováno v:
Clinical and Experimental Rheumatology. 38:371-371
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d19d317ef9c5b949f311f34660028f56
https://doi.org/10.55563/clinexprheumatol/i50k75
https://doi.org/10.55563/clinexprheumatol/i50k75